FDA Adverse Event Malfunction Summary report: N

OMNIPOD INSULIN PUMP

MDR report key: 8560139 · Received April 29, 2019

Report

Report Number
3004464228-2019-03593
Event Type
Malfunction
Date Received
April 29, 2019
Date of Event
February 14, 2019
Report Date
February 15, 2019
Manufacturer
INSULET CORPORATION
Product Code
LZG
UDI-DI
20385081120033
PMA / PMN Number
K162296
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
MA, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

PMA/510(K) # CHANGED FROM K122953 TO K162296. CATALOG NO CHANGED FROM ZXY425 TO ZXP425.

Additional Manufacturer Narrative · 1

THE RETURNED DEVICE WAS EVALUATED AND THE INVESTIGATION FOUND A HOLE IN THE EXPOSED PORTION OF THE SOFT CANNULA. WHEN THE DISTAL TIP WAS MANUALLY OCCLUDED, FLUID DIVERTED THROUGH THE HOLE. ALTHOUGH THE CANNULA WAS DAMAGED, THE TIMING AND CAUSE OF THE DAMAGE COULD NOT BE DETERMINED. LOT RELEASE RECORDS WERE REVIEWED AND THE PRODUCT LOT MET ALL ACCEPTANCE CRITERIA. OMNIPOD INSULIN MANAGEMENT SYSTEM ¿ USER GUIDE: MODEL: ENT450; 17845-5C-AW REV A 10/17. CHECKING YOUR BLOOD GLUCOSE 4 / PAGE 36: WARNINGS: TEST RESULTS GREATER THAN 13.9 MMOL/L MEAN HIGH BLOOD GLUCOSE (HYPERGLYCEMIA). WARNINGS: IF YOU GET RESULTS BELOW 3.9 MMOL/L OR ABOVE 13.9 MMOL/L, BUT DO NOT HAVE SYMPTOMS OF HYPOGLYCEMIA OR HYPERGLYCEMIA (SEE "LIVING WITH DIABETES" ON PAGE 117), REPEAT THE TEST. IF YOU HAVE SYMPTOMS OR CONTINUE TO GET RESULTS THAT FALL BELOW 3.9 MMOL/L OR ABOVE 13.9 MMOL/L, FOLLOW THE TREATMENT ADVICE OF YOUR HEALTHCARE PROVIDER.

Description of Event or Problem · 1

IT WAS REPORTED THE PATIENT¿S BLOOD GLUCOSE REACHED 380 MG/DL AFTER WEARING THE POD BETWEEN 36 AND 48 HOURS ON THE HIP/BUTTOCKS. HYPERGLYCEMIA TREATED BY PATIENT ACTIVATING A NEW POD.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
353310 OMNIPOD INSULIN PUMP PUMP, INFUSION, INSULIN LZG INSULET CORPORATION 19191 L44061 20385081120033

Patients

Seq Age Sex Outcome Treatment
1